Iroxanadine

• Target :

  HSP|||p38 MAPK

• Related Pathways :

  Metabolism|||Cytoskeletal Signaling|||MAPK

• Purity :

  >99.99%

• Bioactivity :

  Iroxanadine (BRX-005) is a Novel small molecule MAPK p38 inhibitor that induces phosphorylation of p38 SAPK and induces concentration-dependent relaxation in guinea pig pulmonary artery preparations precontracted with phenylephrine.13480-84-5

• Smiles :

  C(C1NC(=NOC1)C=2C=CC=NC2)N3CCCCC3

• Molecular Formula :

  C14H20N4O

• Molecular Weight :

  260.33

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  203805-20-3